Biontech SE
NASDAQ:BNTX

  • LAST PRICE
    119.8000
  • TODAY'S CHANGE (%)
    0.8000 (0.6723%)
  • Bid / Lots
    120.0000/ 7
  • Ask / Lots
    120.7800/ 1
  • Open / Previous Close
    118.8000 / 119.0000
  • Day Range
    117.9400
    120.0900
  • 52 Week Range
    76.5301
    131.4900
  • Volume
    946,237

Search Criteria

Click on magnifying glass icon to search

CompanyCountrySymbol

Charts

Price Comparison Graph. See accessible table below
Data delayed at least 15 minutes.

Biotechnology Industry Peers

CompanyMarket CapP/E Ratio (TTM)EPS Growth (5yr)
BNTX
Biontech SE
28.3B
-51.8x
---
BGNE
Beigene Ltd
26.3B
-46.0x
---
MRNA
Moderna Inc
24.3B
-4.0x
---
ALNY
Alnylam Pharmaceuticals Inc
34.9B
-428.9x
---
ARGX
argenx SE
32.9B
-156.1x
---
INCY
Incyte Corp
13.0B
189.6x
+39.11%
As of 2024-10-03

Company Information

BioNTech SE is a Germany-based clinical-stage biotechnology company. The Company focuses on patient-specific immunotherapies for the treatment of cancer and other serious diseases. The Company is providing technologies including mRNA-based therapies, cell therapies, small molecules and antibodies, which can be utilized for specific purposes or can be even combined with each other in a synergistic manner. It also develops a broad product pipeline using different scientific approaches and technology platforms, including individualized mRNA-based product candidates, chimeric antigen receptor T-cells, checkpoint immunomodulators, targeted cancer antibodies and small molecules. In addition, the Company offers diagnostic products and drug discovery services for other therapeutic areas, including infectious diseases, allergies and autoimmune disorders.

Contact Information

Headquarters
An der Goldgrube 12MAINZ, Germany 55131
Phone
---
Fax
---

Executives

Independent Chairman of the Supervisory Board
Helmut Jeggle
Chief Executive Officer, Member of the Management Board
Ugur Sahin
Independent Deputy Chairman of the Supervisory Board
Ulrich Wandschneider
Chief Financial Officer
Jens Holstein
Chief Operating Officer, Member of the Management Board
Sierk Poetting

Ratings

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

Reports

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals

Market Cap
$28.3B
Revenue (TTM)
$3.0B
Shares Outstanding
237.8M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
0.24
EPS
$-2.31
Book Value
$94.06
P/E Ratio
-51.8x
Price/Sales (TTM)
9.5
Price/Cash Flow (TTM)
---
Operating Margin
-32.49%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Calendar

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.